Upgrade to SI Premium - Free Trial

RBC Capital Reiterates Outperform Rating on Abbott Labs (ABT), 'dips create opportunity'

October 16, 2025 6:17 AM
RBC Capital analyst Shagun Singh reiterated an Outperform rating and $147.00 price target on Abbott Labs (NYSE: ABT).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles